Engagement of IL-1 receptor accessory protein (IL-1RAcP) with the monoclonal antibody AY19 provides co-activating signals and prolongs the CD2-induced proliferation of peripheral blood lymphocytes

Immunology Letters

Volumn 139, Issue 1-2, 2011, Pages 52-57

  Mansur, Indra Gusti ^a,b,c   Schiavon, Valérie ^a,b   Giustiniani, Jérôme ^d   Bagot, Martine ^a,b   Bensussan, Armand ^a,b   Marie Cardine, Anne ^a,b  

^a SAINT LOUIS HOSPITAL   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITY OF INDONESIA   (Indonesia)

^d INSTITUT JEAN GODINOT   (France)

Author keywords

Human monoclonal antibody; IL 1RacP; Lymphocytes activation

Indexed keywords

CD2 ANTIGEN; INTERLEUKIN 1 RECEPTOR ACCESSORY PROTEIN; INTERLEUKIN 7 RECEPTOR; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY AY19; UNCLASSIFIED DRUG;

ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MOLECULAR WEIGHT; MONOCYTE; NATURAL KILLER CELL; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PURIFICATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGENS; ANTIGENS, CD2; CELL LINE; CELL PROLIFERATION; HUMANS; INTERLEUKIN-1 RECEPTOR ACCESSORY PROTEIN; LEUKOCYTES, MONONUCLEAR; LYMPHOCYTE ACTIVATION; LYMPHOCYTES; MICE; MOLECULAR SEQUENCE DATA; NIH 3T3 CELLS; PROTEIN BINDING;

EID: 79960700382     PISSN: 01652478     EISSN: 18790542     Source Type: Journal    
DOI: 10.1016/j.imlet.2011.04.015     Document Type: Article

References (21)

1. Wesche H., Henzel W.J., Shillinglaw W., Li S., Cao Z. MyD88: an adapter that recruits IRAK to the IL-1 receptor complex. Immunity 1997, 7:837-847.
2. Dunne A., O'Neill L.A. The interleukin-1 receptor/Toll-like receptor superfamily: signal transduction during inflammation and host defense. Sci STKE 2003, 2003:re3.
3. Chackerian A.A., Oldham E.R., Murphy E.E., Schmitz J., Pflanz S., Kastelein R.A. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 2007, 179:2551-2555.
4. Schmitz J., Owyang A., Oldham E., Song Y., Murphy E., McClanahan T.K., et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005, 23:479-490.
5. Towne J.E., Garka K.E., Renshaw B.R., Virca G.D., Sims J.E. Interleukin (IL)-1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 2004, 279:13677-13688.
6. Debets R., Timans J.C., Churakowa T., Zurawski S., de Waal Malefyt R., Moore K.W., et al. IL-18 receptors, their role in ligand binding and function: anti-IL-1RAcPL antibody, a potent antagonist of IL-18. J Immunol 2000, 165:4950-4956.
7. Jensen L.E., Muzio M., Mantovani A., Whitehead A.S. IL-1 signaling cascade in liver cells and the involvement of a soluble form of the IL-1 receptor accessory protein. J Immunol 2000, 164:5277-5286.
8. Jensen L.E., Whitehead A.S. Expression of alternatively spliced interleukin-1 receptor accessory protein mRNAs is differentially regulated during inflammation and apoptosis. Cell Signal 2003, 15:793-802.
9. Smith D.E., Hanna R., Della F., Moore H., Chen H., Farese A.M., et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity 2003, 18:87-96.
10. Smeets R.L., Joosten L.A., Arntz O.J., Bennink M.B., Takahashi N., Carlsen H., et al. Soluble interleukin-1 receptor accessory protein ameliorates collagen-induced arthritis by a different mode of action from that of interleukin-1 receptor antagonist. Arthritis Rheum 2005, 52:2202-2211.
11. Yodoi J., Teshigawara K., Nikaido T., Fukui K., Noma T., Honjo T., et al. TCGF (IL 2)-receptor inducing factor(s). I. Regulation of IL 2 receptor on a natural killer-like cell line (YT cells). J Immunol 1985, 134:1623-1630.
12. Bagot M., Echchakir H., Mami-Chouaib F., Delfau-Larue M.H., Charue D., Bernheim A., et al. Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma. Blood 1998, 91:4331-4341.
13. Shevchenko A., Wilm M., Vorm O., Mann M. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996, 68:850-858.
14. Giustiniani J., Bensussan A., Marie-Cardine A. Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J Immunol 2009, 182:63-71.
15. Mansur I.G., Leca G., Pratt J.C., Degos L., Boumsell L., Bensussan A. Identification of a novel functional 85-kD glycoprotein restricted to long-term dividing human lymphocytic lines. Hum Immunol 1993, 37:31-38.
16. Majdic O., Kohl P., Pickl W.F., Knapp W. Myeloid blind panel flow cytometric analysis: differentially regulated molecules on dendritic cells as defined by myeloid blind panel monoclonal antibodies. Leukocyte typing VI white cell differentiation antigens 1997, 1050-1052. Garland Publishers Inc. T. Kishimoto, S. Goyert, H. Kikutani (Eds.).
17. Huet S., Wakasugi H., Sterkers G., Gilmour J., Tursz T., Boumsell L., et al. T cell activation via CD2 [T, gp50]: the role of accessory cells in activating resting T cells via CD2. J Immunol 1986, 137:1420-1428.
18. Abadie-Fauconnier L., Carosella E.D., Gluckman E., Mansur I.G., Menier C., Boumsell L., et al. Delineation of human cord blood hematopoietic progenitor cell subsets with a unique monoclonal antibody AY19. Tissue antigens 1998, 51:520-527.
19. Miyazaki S., Sugawara H., Tamura T., Okayama T., Ishii J., Shimura J., et al. Cross-lineage (blind panel) study and human leukocyte differentiation antigen database. Leukocyte typing VI white cell differentiation antigens 1997, 3-20. Garland Publishers Inc. T. Kishimoto, S. Goyert, H. Kikutani (Eds.).
20. Yoza B.K., Brooks J.W., Mizel S.B. Induction of AP-1 transcription factor components during T-cell activation by interleukin 1 and phorbol esters. Cell Growth Differ 1992, 3:677-684.
21. Meuer S.C., Hussey R.E., Cantrell D.A., Hodgdon J.C., Schlossman S.F., Smith K.A., et al. Triggering of the T3-Ti antigen-receptor complex results in clonal T-cell proliferation through an interleukin 2-dependent autocrine pathway. Proc Natl Acad Sci U S A 1984, 81:1509-1513.